Le Lézard
Classified in: Health
Subject: SVY

Global Nebulization Masks Market Report 2019-2023


DUBLIN, Dec. 14, 2018 /PRNewswire/ --

The "Global Nebulization Masks Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The nebulization masks market will register a CAGR of almost 3% by 2023.

The rising focus on improvements in materials and design of nebulization masks is expected to boost the market growth. There is an increase in focus on the development of nebulization masks with new materials. One of the materials being investigated is cotton woven fabric as it can resist and recover from wrinkles and creases.

Market Overview

Increasing prevalence of respiratory disorders

The increasing prevalence of respiratory disorders that require nebulization procedure with the help of nebulizer medicines is likely to boost the nebulization masks market.

Limitations and disadvantages associated with nebulization masks

Nebulization masks have a few limitations and disadvantages that may restrict the growth of the market to a certain extent. The use of a nebulization masks increases the amount of aerosol deposited on the face, in eyes, and into the nose, thereby causing irritation.

For the detailed list of factors that will drive and challenge the growth of the nebulization masks market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Medical Depot and OMRON, the competitive environment is quite intense. Factors such as the growing inclination toward home healthcare and the marketing strategies of vendors, will provide considerable growth opportunities to nebulization masks manufactures. Allied Healthcare Products, Besmed Health Business, Medical Depot, OMRON, PARI, and Koninklijke Philips are some of the major companies covered in this report.

With the presence of a considerable number of companies, this market appears to be fragmented. Several vendors have entered into agreements with group purchasing organizations (GPOs), which provide them easy access to hospitals and opportunities to increase the sales of their nebulization masks. Vendors are also increasingly focusing on conducting clinical and health economics studies to document cost savings and benefits of their nebulization masks.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

PART 13: VENDOR ANALYSIS

PART 14: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/mfdgmt/global?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: